“…difficile toxin A, like other ADP-ribosylating toxins, must bind to intestinal epithelial cells in vivo to exert its adjuvant activity. It is possible that the differences in the immune responses elicited by CT, EtxB, and TxA C314 are due, at least in part, to different properties for binding to the gastrointestinal and nasopharyngeal mucosa (39,46). Indeed, the sugar binding properties can confine lectins to specific cell populations, such as M cells in the Peyer's patches or the follicle-associated epithelium in nasopharyngeal tissue (5,24).…”